Ascom delivers the Digistat clinical software solution to a leading Swiss hospital

October 30, 2018

Ascom was selected by a leading Swiss hospital to deliver the software solution Ascom Digistat. The contract amounts to around half a million Swiss francs.

The delivered solutions will support the enhanced clinical workflows such as ICU workflow management, alerting and care team collaboration and communication through the Ascom Digistat software for the integration of medical devices, a central data display, alerts, events and video surveillance of hospital beds. Moreover, the project will ensure the integration of the hospital's existing ward system and technical alarms, the Ascom Myco 2 smart device specially developed for the hospital environment, as well as dynamic assignment of alerts.

Ascom is providing these solutions for a new building of the hospital, where intensive medical care services are provided across different wards and clinical locations. The cutting-edge communication and alarm management solutions provides optimized alerting possibilities, mobilization of information and the visualization of medical devices on a centralized dashboard.

"This important client win demonstrates once again that the Ascom Healthcare Platform is a state-of-the-art workflow solution highly valued by hospitals around the world. We are happy to be able to provide our solutions to a prestigious customer in our home country and provide them with actionable clinical insights, leading to informed decisions," emphasizes Francis Schmeer, Chief Sales & Marketing Officer of Ascom.

Back to list

Download

This document does not constitute an offer or solicitation to subscribe for, purchase or sell any securities. This document is not being issued in the United States of America or the United Kingdom and should not be distributed in any jurisdiction in a manner where such distribution would not comply with regulatory requirements. In particular, this document may not be distributed into the United States, to United States persons or to publications with a general circulation in the United States. In addition, the securities of Ascom have not been and will not be registered in any jurisdiction outside Switzerland. The securities of Ascom may not be offered, sold or delivered and no solicitation to purchase such securities may be made within the United States or to U.S. persons absent an applicable exemption from the registration requirements of the United States securities laws or within any other jurisdiction and in a manner where such offer, sale, delivery or solicitation might not be in compliance with regulatory requirements (including the United Kingdom).

News